Votes


Actions


Jun 01, 2023

Office of the Governor

Approved by the Governor. Chapter 151.

May 26, 2023

Office of the Governor

Enrolled and delivered to Governor.

May 23, 2023

Senate

Read third time. Passed. Title approved. (Yeas: 42, Nays: None.) To Senate. In Senate. To enrollment.

May 22, 2023

Senate

Read second time.

May 19, 2023

Senate

From committee: Do pass.

Apr 26, 2023

Senate

From printer. To re-engrossment. Re-engrossed. Second reprint. To Assembly. In Assembly. Read first time. Referred to Committee on Commerce and Labor. To committee.

Apr 25, 2023

Senate

Read third time. Amended. (Amend. No. 530.) Reprinting dispensed with. Read third time. Passed, as amended. Title approved. (Yeas: 21, Nays: None.) To printer.

Apr 24, 2023

Senate

Taken from General File. Placed on General File for next legislative day.

Apr 21, 2023

Senate

Taken from General File. Placed on General File for next legislative day.

Apr 20, 2023

Senate

From printer. To engrossment. Engrossed. First reprint. Taken from General File. Placed on General File for next legislative day.

Apr 19, 2023

Senate

Read second time. Amended. (Amend. No. 240.) To printer.

Apr 18, 2023

Senate

From committee: Amend, and do pass as amended. Placed on Second Reading File.

Mar 01, 2023

Senate

To committee.

Feb 27, 2023

Senate

From printer.

Feb 23, 2023

Senate

Read first time. Referred to Committee on Commerce and Labor. To printer.

Bill Text

Bill Text Versions Format
As Introduced PDF
Amendment 240 PDF
Reprint 1 PDF
Amendment 530 PDF
Reprint 2 PDF
As Enrolled PDF

Related Documents

Document Format
SB194_Support Testimony_Heidi Englund PDF
SB194_Support Testimony_Vivian Leal PDF
SB194_7 Support Letters from various organizations and citizens PDF
SB194_Chart of annual price trends for MS disease modifying therapies_Vivian Leal_Multiple Sclerosis Advocate PDF
SB194_National Mulitple Sclerosis Society Step Therapy Position Statement_Vivian Leal_Multiple Sclerosis Advocate PDF
SB194_Work Session Document_Cesar Melgarejo_Committee Policy Analyst PDF
SB194 Letter of Support, submitted by A. Barber, MD, FACS, on behalf of the Nevada Oncology Society (NOS) and the Assn. for Clinical Oncology (ASCO) PDF
SB194 Letter of Support, submitted by A. Cohen, MD, on behalf of Comprehensive Cancer Centers of Nevada (CCCN) PDF
SB194 Letter of Support, submitted by J. Cooper, Executive Director, Alliance for Patient Access PDF
SB194 Letter of Support, submitted by J. Cooper, Executive Director, Movement Disorders Policy Coalition, on behalf of multiple organizations PDF
SB194 Letter of Support, submitted by T. A. Cronin, Jr., on behalf of the Nevada Society for Dermatology and Dermatologic Surgery PDF
SB194 Letter of Support, submitted by A. DeBattista, Executive Director, on behalf of Derma Care Access Network (DCAN) PDF
SB194 Letter of Support, submitted by H. Grauso PDF
SB194 Letter of Support, submitted by C. Herington, MBA, Executive Director, on behalf of the Nevada Cancer Coalition (NCC) PDF
SB194 Letter of Support, submitted by L. Laube, State Government Relations Manager, West, on behalf of multiple organizations PDF
SB194 Letter of Support, submitted by K. Serota, Program Director, on behalf of the Vision Health Advocacy Coalition PDF
SB194 Letter of Support, submitted by L. Videnieks, Executive Director, on behalf of the Headache and Migraine Policy Forum (HMPF) PDF
SB194 Proposed Amendment, submitted by P. Young on behalf of Pharmaceutical Care Management Association PDF
SB194 Letter of Support, submitted by C. Yung, M.D. PDF
SB194 Work Session Document PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Nevada Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.